Explore more publications!

Automotive Industry Today: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Automotive Industry Today.

Press releases published on April 21, 2026

Top Diode Manufacturer News: Tongke Electronic Co., Ltd Strengthens Global Semiconductor Supply
Industrial Sewing Machines Market to Reach US$ 6.0 Billion by 2033, According to Persistence Market Research
Top Diesel Engine Manufacturer News: Xingtai Haoheng Trading Co., Ltd. Spotlight
Car Detailing Service Market Size worth USD 65.49 Billion by 2032, Exclusive Report by Maximize Market Research
Chinese Top 3 Seamless Steel Pipe Manufacturers in 2026: Pioneering Global Precision and Industry Leadership
Furuno to exhibit at WSTS, North America’s leading timing & sync event
Applied Materials Announces Advantest as Innovation Partner for EPIC Platform in Silicon Valley
Xeltis receives CE mark for aXess™, its aXess hemodialysis conduit™, as it moves to commercialization
Advantest Announces Strategic Partnership with Applied Materials and Joins EPIC Platform
creditpath.io Expands Advisor First Credit Platform with New Lending Solutions and Capital Access
Teledyne e2v introduces the Caiman module: a compact imaging solution for low light imaging
Teledyne e2v、低照度イメージング向けのコンパクトなイメージングソリューションCaimanモジュールを発表
Eclipse Foundation Launches Open VSX Managed Registry
Payment Failures Put £1.7 Billion in UK Retail & Hospitality Sales at Risk Each Year
Teledyne e2v stellt das Modul Caiman vor: eine kompakte Bildgebungslösung für Aufnahmen bei schlechten Lichtverhältnissen
Teledyne e2v가 저조도 이미징을 위한 컴팩트 이미징 솔루션인 Caiman 모듈을 선보입니다.
Teledyne e2v 公司推出 Caiman模組:一 款針對低光成像的緊湊型成像解決方案
Grady Manual Therapy Ltd Champions "Exercise is Medicine" to Deliver Professional Sports Health Care to Everyday Athletes in Hong Kong
Groundbreaking approaches such as cell therapies on the horizon for transformation of neural hearing loss, Rinri Therapeutics’ review1 shows
Amphista Therapeutics presents the discovery, characterisation and chemical structure of AMX-883, an orally bioavailable, highly potent and selective DCAF16 degrader of BRD9 at AACR 2026

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions